ArticleIn silico pharmacology2026

In-silico screening of anti-cancer natural compounds targeting NF-κB as identification of potential therapeutic inhibitor.

Jarin Tasnim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.